Therefore, we conducted the current study to analyze the serum levels of TIMP4 in patients with RA, and assessed the correlation between TIMP4 and RA inflammatory biomarkers to evaluate the potential of TIMP4 as a novel serological biomarker for RA. This evidence concerns the gene TIMP4 and rheumatoid arthritis.